JNJ vs PFE
By Alex · Tickerpine
Johnson & Johnson vs Pfizer Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JNJ | PFE |
|---|---|---|
| Price | $254.66 | $24.29 |
| Market cap | $613.02B | $138.44B |
| P/E ratio | 29.5 | 18.5 |
| ROE | 26.42% | 8.31% |
| Profit margin | 21.83% | 11.83% |
| Revenue growth | 9.90% | 5.40% |
| Dividend yield | 2.10% | 7.08% |
| Beta | 0.26 | 0.29 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JNJ vs PFE in plain English
- JNJ is the bigger company — about 4.4× the market cap of PFE.
- PFE is cheaper on earnings (P/E 18.5 vs 29.5).
- JNJ earns a higher return on equity (26% vs 8%).
- JNJ is growing revenue faster (10% vs 5%).
- PFE has the higher dividend yield (7.08% vs 2.10%).
How would $1,000 have done in each?
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
PFE return calculator
See what $1,000 in Pfizer Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.